To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis

NCT03053739 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Associated Pulmonary Arterial Hypertension

Interventions

DRUG: Sildenafil 20mg and Bosentan 62.5mg
DRUG: Sildenafil 20mg and Placebo

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh